Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
VALEANT PHARMACEUTICALS INTL INC
T.VRX
Healthcare
Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:VRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(170)
•••
MNK3240
X
View Profile
View Bullboard History
Post by
MNK3240
on Aug 10, 2017 3:27pm
Re: Paulson and Company PR and market mechanism
This is kind of funny! These big firms (and their PRs) don't really need to say anything, their actions speak volume. It's not just anybody, when they inc/dec the portfolio size, market gets
...more
(0)
•••
FerrariPalmbeac
X
View Profile
View Bullboard History
Post by
FerrariPalmbeac
on Aug 10, 2017 10:03am
Paulson and Company PR
https://ih.advfn.com/p.php?pid=nmona&article=75419863
(0)
•••
FerrariPalmbeac
X
View Profile
View Bullboard History
Post by
FerrariPalmbeac
on Aug 10, 2017 9:59am
Paulson & Co., Inc. Reiterates Confidence In Valeant
Paulson & Co., Inc. Reiterates Confidence In Valeant Strategy
(0)
•••
FerrariPalmbeac
X
View Profile
View Bullboard History
Post by
FerrariPalmbeac
on Aug 10, 2017 9:11am
VRX VIEW,
VRX VIEW, https://topactu.net/2017/08/valeant-pharmaceuticals-international-inc-vrx-has-a-market/
(5)
•••
Abruzzo
X
View Profile
View Bullboard History
Post by
Abruzzo
on Aug 09, 2017 9:28pm
BRIEF-Valeant says subsidiaries in Australia are under audit
Aug 9 (Reuters) - Valeant - * Says subsidiaries in australia are under audit by the australian tax office for various years beginning in 2010 * Says the australian tax office issued a notice of
...more
(42)
•••
deepblue
X
View Profile
View Bullboard History
Post by
deepblue
on Aug 09, 2017 7:42pm
Thanks for the Cheapies!
more for me..
(30)
•••
domcolumba
X
View Profile
View Bullboard History
Comment by
domcolumba
on Aug 09, 2017 4:11pm
RE:VRX - I'm away
Hey Ichimek I get my itchimoku signal when my hemorrhoids start to flare up. Today I got that itchy feeling so I bought more VRX at the end of the day. Dom PS does Valeant have anything
...more
(0)
•••
Ichimek
X
View Profile
View Bullboard History
Post by
Ichimek
on Aug 09, 2017 3:54pm
VRX - I'm away
We might have itchimoku signal (info), but it was neglected. Now I'd stay away. I already made some nice cash from VRX.
(121)
•••
mtgfree1
X
View Profile
View Bullboard History
Comment by
mtgfree1
on Aug 09, 2017 11:26am
RE:We all have seen this before and than goes to $22+
Could not resist, filled 18.25
(121)
•••
mtgfree1
X
View Profile
View Bullboard History
Post by
mtgfree1
on Aug 09, 2017 11:17am
We all have seen this before and than goes to $22+
Tomorrow or Friday $20+
(0)
•••
RobPhil
X
View Profile
View Bullboard History
Post by
RobPhil
on Aug 09, 2017 10:58am
Valeant cuts revenue forecast - 2Q 2017 Earnings
Revenue during the quarter fell 8 percent to $2.23-billion in the second quarter ended June 30. This was due to declines in volume and pricing of its generic and neurology products. Net loss narrowed
...more
(170)
•••
MNK3240
X
View Profile
View Bullboard History
Post by
MNK3240
on Aug 09, 2017 9:52am
Re: Analysts target price and market behaviour
It's kind of interesting to watch that recently the analysts increase the target price for stocks and the price go down so much that they have to hide. CP rail target price increased to $229 based
...more
(121)
•••
mtgfree1
X
View Profile
View Bullboard History
Comment by
mtgfree1
on Aug 08, 2017 3:34pm
RE:VRX up 10% Pre-Market
Nothing has changed just shorts are doing the work. hoinb back to 22 tomorrow or day after
(121)
•••
mtgfree1
X
View Profile
View Bullboard History
Comment by
mtgfree1
on Aug 08, 2017 3:33pm
RE:RE:RE:RBC raised price on Valeant pharmaceutical to $21
We have seen that last week and is going to be this week . i can see $22 by the end of the week
(170)
•••
MNK3240
X
View Profile
View Bullboard History
Post by
MNK3240
on Aug 08, 2017 10:41am
Reasonably good earnings, stock price up
At last based on earnings and guidance, the stock price has reacted at least for a session, that's good. The way CP rail and CNR went down on very good earnings (particularly CP rail), it seemed
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >